Economic Evaluation Methods and Pharmacoeconomics, Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada.
Patient. 2011;4(2):125-31. doi: 10.2165/11586060-000000000-00000.
Côte d'Ivoire, a West African country, has decided to set up a formulary as part of its universal health insurance (UHI) program. One of its goals will be to facilitate access to safe and efficacious drugs. To guarantee transparency throughout the formulary listing process, it is important to select and value relevant decision criteria for that purpose.
To investigate the preferences of healthcare professionals (physicians) when selecting reimbursable drugs and to analyze trade-offs between criteria for formulary listing in Côte d'Ivoire.
Choice sets based on four attributes (cost effectiveness of treatments, severity of the disease for which the treatments are indicated, age of the population affected by diseases considered, and social class affected by diseases considered [poor, rich]) were presented in a self-completion questionnaire.
Analysis of questionnaire responses showed that 'cost effectiveness', 'severity of disease', and 'social class' were significant attributes in responder's preferences for reimbursable drugs. More specifically, respondents' choices were more sensitive to drugs that are very cost effective, that target very severe disease, and that target diseases in poor people.
This explorative study enabled us to elicit the preferences of a sample of healthcare professionals (physicians) for reimbursed drug selection criteria in Côte d'Ivoire using the discrete-choice experiment method. Further work is required to achieve the ultimate objective of developing a formulary for Côte d'Ivoire.
科特迪瓦是西非的一个国家，已决定为其全民健康保险（UHI）计划设立一个处方集。其目标之一是为安全有效的药物提供便利。为了确保在整个处方集编制过程中保持透明度，选择和评估相关决策标准非常重要。
调查医疗保健专业人员（医生）在选择可报销药物时的偏好，并分析科特迪瓦处方集编制标准之间的权衡。
在自我完成的问卷中，提供了基于四个属性（治疗的成本效益、治疗所针对疾病的严重程度、受考虑疾病影响的人群年龄以及受考虑疾病影响的社会阶层[贫困、富裕]）的选择集。
对问卷回答的分析表明，“成本效益”、“疾病严重程度”和“社会阶层”是应答者对可报销药物偏好的重要属性。具体来说，受访者的选择对非常具有成本效益的药物、针对严重疾病的药物以及针对贫困人口疾病的药物更为敏感。
这项探索性研究使用离散选择实验方法，使我们能够了解科特迪瓦医疗保健专业人员（医生）对报销药物选择标准的偏好。需要进一步努力，以实现为科特迪瓦制定处方集的最终目标。
